Back
Direxion Dly Rbtc AI Atmtn Bl 2X ETF Vs. Corcept Therapeutics Industry Stock Comparison
Buy
62
UBOT
Direxion Dly Rbtc AI Atmtn Bl 2X ETF
Last Price:
22.35
Seasonality Move:
0.42%
Buy
68
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Buy
62
Direxion Dly Rbtc AI Atmtn Bl 2X ETF (UBOT)
is a Buy
Is Direxion Dly Rbtc AI Atmtn Bl 2X ETF a Buy, Sell or Hold?
- The current Direxion Dly Rbtc AI Atmtn Bl 2X ETF [UBOT] share price is $21.26. The Score for UBOT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- UBOT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UBOT Stock Price Chart
What is Direxion Dly Rbtc AI Atmtn Bl 2X ETF's stock price today?
-
The Direxion Dly Rbtc AI Atmtn Bl 2X ETF share price today is $21.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UBOT is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $42.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
UBOT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 48.14 | Sell |
| Chaikin Money Flow: | -3745 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.67 - 22.99) | Sell |
| Bollinger Bands (100): | (21.08 - 24.04) | Sell |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.36 | Buy |
| Relative Strength Index (14 RSI): | 82.3 | Buy |
| Chaikin Money Flow: | 670376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.47 - 37.45) | Buy |
| Bollinger Bands (100): | (28.16 - 35.86) | Buy |
UBOT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.05 | Buy |
| 20-day SMA: | 21.82 | Sell |
| 50-day SMA: | 21.76 | Sell |
| 200-day SMA: | 22.28 | Sell |
| 8-day EMA: | 21.27 | Sell |
| 20-day EMA: | 21.41 | Sell |
| 50-day EMA: | 21.77 | Sell |
| 200-day EMA: | 21.68 | Sell |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.44 | Buy |
| 20-day SMA: | 35.75 | Buy |
| 50-day SMA: | 34.88 | Buy |
| 200-day SMA: | 28.43 | Buy |
| 8-day EMA: | 38.24 | Buy |
| 20-day EMA: | 36.43 | Buy |
| 50-day EMA: | 34.68 | Buy |
| 200-day EMA: | 30.05 | Buy |
Direxion Dly Rbtc AI Atmtn Bl 2X ETF Earnings Growth & UBOT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
Direxion Dly Rbtc AI Atmtn Bl 2X ETF Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||